Press release
Inactivated Vaccines Global Market Report 2024: Key Players, Demand Patterns And Forecasts 2033 | Pfizer Inc., Johnson & Johnson Services Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A.
Inactivated Vaccines Market Size
The Business Research Company offers in-depth market insights through Inactivated Vaccines Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The inactivated vaccines market size has grown steadily in recent years. It will grow from $5.95 billion in 2023 to $6.19 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to polio eradication efforts, influenza vaccination programs, emerging infectious diseases, regulatory approvals.
The inactivated vaccines market size is expected to see steady growth in the next few years. It will grow to $7.33 billion in 2028 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to pandemic preparedness, expanding vaccine coverage, biomanufacturing advancements, health equity initiatives. Major trends in the forecast period include mrna vaccine platforms, combination vaccines, thermostable vaccines, digital vaccine passports.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13018&type=smp
Market Segmentation:
The main types of inactivated vaccines are viral and bacterial vaccines. A viral vaccine is a biological preparation containing weakened or inactivated virus components to stimulate the immune system and provide immunity against the targeted viral infection. These are inactivated by solvent detergent, radiation, pH concentration, heat inactivation and others and are distributed by hospital pharmacies, retail pharmacies and others.
Major Driver - Rising Prevalence Of Infectious Diseases Boost Inactivated Vaccines Market In Combating Diseases
The increasing prevalence of infectious diseases is expected to propel the growth of the inactivated vaccine market going forward. Infectious diseases are illnesses caused by pathogens such as bacteria, viruses, fungi, or parasites that can spread from person to person, resulting in a wide range of symptoms and health complications. Tuberculosis is one type of infectious disease. Inactivated vaccines use non-living pathogens to stimulate an immune response, effectively preventing diseases like polio, hepatitis A and influenza. For instance, in October 2022, according to the Global Tuberculosis Report published by the World Health Organization, a Switzerland-based global health agency, there will be a 4.5% increase in the global incidence of tuberculosis from the projected 10.1 million cases to 10.6 million cases in 2021. The majority of tuberculosis cases were reported in the Southeast Asia region, accounting for 45% of the total, followed by Africa with 23% of the cases. Therefore, the increasing prevalence of infectious diseases is driving the growth of the inactivated vaccine market.
Competitive Landscape:
Major players in the inactivated vaccines market are Pfizer Inc., Johnson & Johnson Services Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., CanSino Biologics Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Bavarian Nordic A/S., Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd., .
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report
Top Trend - Innovative Advancements In Inactivated Vaccines By Leading Companies For Disease Prevention
Major companies operating in the inactivated vaccines market are introducing innovative and advanced inactivated vaccines to sustain their position in the market. An inactivated vaccine contains inactivated virus particles, bacteria, or other pathogens that have been developed in culture and subsequently killed to destroy disease-producing ability. For instance, in January 2022, GSK plc, a UK-based pharmaceutical and biotechnology company, released a new inactivated vaccination to aid with shingles protection named Shingrix to prevent shingles (Herpes zoster). Shingrix is a non-live, recombinant subunit adjuvanted vaccination administered intramuscularly in two doses. The vaccine's initial indication was for individuals 50 years and older. It has lately been expanded to cover persons 18 and older at a higher risk of developing shingles due to immunodeficiency or immunosuppression caused by a known illness or treatment.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Inactivated Vaccines Market Characteristics
3. Inactivated Vaccines Market Trends And Strategies
4. Inactivated Vaccines Market - Macro Economic Scenario
5. Inactivated Vaccines Market Size And Growth
…..
27. Inactivated Vaccines Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Inactivated Vaccines Global Market Report 2024: Key Players, Demand Patterns And Forecasts 2033 | Pfizer Inc., Johnson & Johnson Services Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A. here
News-ID: 3404501 • Views: …
More Releases from The Business Research Company
Global High-Resolution Anoscopy Market Outlook 2025-2034: Trends, Innovations, A …
The High-Resolution Anoscopy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the High-Resolution Anoscopy Market Size and Projected Growth Rate?
The market size for high-resolution anoscopy has experienced significant growth over the past few years. The market is predicted to increase from $15.03 billion…
Condyloma Acuminata Treatment Market Size Projected To Reach $2.2 Billion By 203 …
"The Condyloma Acuminata Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Condyloma Acuminata Treatment Market Size During the Forecast Period?
In the past few years, the condyloma acuminata treatment market has seen significant growth. The market value, which is anticipated to…
Household Type Fans Market Forecast 2025-2034: Comprehensive Analysis And Growth …
"The Household Type Fans Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Household Type Fans Market?
The market size for household fans has seen consistent expansion in recent years. The projections indicate an increase from $32.22 billion in 2024…
Grain Fumigants Industry Report 2025-2034: Market Dynamics, Trends, And Forecast …
The Grain Fumigants Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Grain Fumigants Market Size During the Forecast Period?
The Grain Fumigants Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This…
More Releases for Inactivated
Guardians Unleashed: Harnessing Inactivated Vaccines for Global Health
Data Bridge Market Research analyses a growth rate in the inactivated vaccines market in the forecast period 2023-2030. The expected CAGR of inactivated vaccines market is tend to be around 7.10% in the mentioned forecast period. The market is valued at USD 40,763.4 million in 2022, and it will grow upto USD 70,564.48 million by 2030. In addition to the market insights such as market value, growth rate, market segments,…
Global Inactivated Influenza Vaccine Market Research Report 2023-2029
Global Leading Market Research Publisher QYResearch announces the release of its lastest report "Global Inactivated Influenza Vaccine Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application". Based on historical analysis (2018-2022) and forecast calculations (2023-2029), this report provides a comprehensive analysis of the global Inactivated Influenza Vaccine market, including market size, share, demand, industry development status, and forecasts for the next few years. Provides…
Inactivated Vaccine for Swine Mycoplasma Pneumonia Market: Market for Inactivate …
Global Inactivated Vaccine for Swine Mycoplasma Pneumonia Market Overview:
The Inactivated Vaccine for Swine Mycoplasma Pneumonia market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Inactivated Vaccine for Swine Mycoplasma Pneumonia market has experienced significant growth, driven by factors such as…
Inactivated Vaccine for Swine Mycoplasma Pneumonia Market: Market for Inactivate …
Global BPH Treatment Equipment Market Overview:
The BPH Treatment Equipment market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the BPH Treatment Equipment market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and globalization. This growth…
Global Trivalent Inactivated Influenza Vaccine Market - Opportunities & Forecast …
Dhirtek Business Research and Consulting recently released its most comprehensive research report to date on the global trivalent inactivated influenza vaccine market. Through extensive research, analysts have provided an extensive look into the market's drivers and restraints, and identified the key milestones and trends that will shape its future.
Primary and secondary research methods were used to create this in-depth report. Through the analysis of the research, Dhirtek was…
Global Inactivated Vaccine Market - Forecasts to 2027
According to a new market research report published by Global Market Estimates, the Global Inactivated Vaccine Market is projected to grow at a CAGR value of 10.5% from 2022 to 2027.
Growing health consciousness and government efforts to support vaccination, technological developments and infrastructure upgrades in the healthcare system, increased emphasis on research studies, and cooperation among various top research facilities in the domain to find a new methodology to…
